Format

Send to

Choose Destination
Bone Marrow Transplant. 2003 Aug;32 Suppl 1:S49-51.

Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus.

Author information

1
Northwestern University Medical Center, Chicago, IL 60611, USA.

Abstract

At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care, intravenous pulse cyclophosphamide.

PMID:
12931242
DOI:
10.1038/sj.bmt.1703943
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center